Back

Brief Correspondence

Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population

By: Jean-Nicolas Cornua, Geraldine Cancel-Tassinb c, David G. Coxd e f, Morgan Roupretb c g, Nicolas Koutlidish, Pierre Bigoti, Antoine Valerij, Valerie Ondeta b c, Cécile Gafforya b c, Georges Fournierj, Abdel-Rahmene Azzouzii, Luc Cormierh and Olivier Cussenota b c

European Urology, Volume 70 Issue 1, July 2016, Pages 6-8

Published online: 01 July 2016

Keywords: Prostate-specific antigen, Prostate cancer, Single-nucleotide polymorphisms

Abstract Full Text Full Text PDF (339 KB) Patient Summary

Abstract

Prostate-specific antigen (PSA) is still the cornerstone of prostate cancer (PCa) screening and diagnosis in both research and current clinical practice. Inaccuracy of PSA is partly due to the influence of a number of genetic, clinical, and biological factors modifying PSA blood levels. In the present study, we detailed the respective influence of each factor among age, body mass index (BMI), prostate volume, and five single-nucleotide polymorphisms—rs10788160 (10q26), rs10993994 (10q11), rs11067228 (12q24), rs17632542 (19q13.33), and rs2928679 (8p21)—on PSA values in a cohort of 1374 men without PCa. Our results show that genetic factors, when risk variants are combined, influence PSA levels with an effect size similar to that of BMI. Taken together, the respective correlations of clinical parameters and genetic parameters would make it possible to correct and adjust PSA values more effectively in each individual. These results establish the basis to understand and implement a more personalised approach for the interpretation of PSA blood levels in the context of PCa screening and diagnosis.

Patient summary

Prostate-specific antigen (PSA) values in an individual may vary according to genetic predisposition. The effect size of this variation can be significant, comparable with those resulting from clinical characteristics. Personalised PSA testing should take this into account.

Take Home Message

In men without prostate cancer, genetic influences can have a significant influence on prostate-specific antigen (PSA) values and should be taken into account along with clinical variables to interpret PSA values.

Keywords: Prostate-specific antigen, Prostate cancer, Single-nucleotide polymorphisms.

Footnotes

a Academic Department of Urology, Hôpital Tenon, AP-HP, UPMC Université Paris 06, Paris, France

b Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France

c GRC no. 5, ONCOTYPE-URO, Institut Universitaire de Cancérologie, UPMC Université Paris 06, Paris, France

d INSERM U1052, Cancer Research Center of Lyon, Lyon, France

e Université Lyon 1, Villeurbanne, France

f Centre Léon Bérard, Lyon, France

g Academic Department of Urology, Hôpital Pitié-Salpétrière, AP-HP, UPMC Université Paris 06, Paris, France

h Academic Department of Urology, CHU Dijon, Dijon, France

i Academic Department of Urology, CHU Angers, Angers, France

j Academic Department of Urology, CHU Brest, Brest, France

Corresponding author. Department of Urology, Tenon Hospital, 4 rue de la Chine, 75020 Paris, France.

Place a comment

Your comment *

max length: 5000